Literature DB >> 19089556

Comprehensive detection of causative pathogens using real-time PCR to diagnose pediatric community-acquired pneumonia.

Keiko Hamano-Hasegawa1, Miyuki Morozumi, Eiichi Nakayama, Naoko Chiba, Somay Y Murayama, Reiko Takayanagi, Satoshi Iwata, Keisuke Sunakawa, Kimiko Ubukata.   

Abstract

We have developed a real-time reverse transcription-PCR (RT-PCR) method to detect 13 respiratory viruses: influenza virus A and B; respiratory syncytial virus (RSV) subgroup A and B; parainfluenza virus (PIV) 1, 2, and 3; adenovirus; rhinovirus (RV); enterovirus; coronavirus (OC43); human metapneumovirus (hMPV); and human bocavirus (HBoV). The new method for detection of these viruses was applied simultaneously with real-time PCR for the detection of six bacterial pathogens in clinical samples from 1700 pediatric patients with community-acquired pneumonia (CAP). Of all the patients, 32.5% were suspected to have single bacterial infections; 1.9%, multiple bacterial infections; 15.2%, coinfections of bacteria and viruses; 25.8%, single viral infections; and 2.1%, multiple viral infections. In the remaining 22.6%, the etiology was unknown. The breakdown of suspected causative pathogens was as follows: 24.4% were Streptococcus pneumoniae, 14.8% were Mycoplasma pneumoniae, 11.3% were Haemophilus influenzae, and 1.4% were Chlamydophila pneumoniae. The breakdown of viruses was as follows: 14.5% were RV, 9.4% were RSV, 7.4% were hMPV, 7.2% were PIV, and 2.9% were HBoV. The new method will contribute to advances in the accuracy of diagnosis and should also result in the appropriate use of antimicrobials.

Entities:  

Mesh:

Year:  2008        PMID: 19089556      PMCID: PMC7087782          DOI: 10.1007/s10156-008-0648-6

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  40 in total

Review 1.  Community-acquired pneumonia in children.

Authors:  Kenneth McIntosh
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

2.  Cloning of a human parvovirus by molecular screening of respiratory tract samples.

Authors:  Tobias Allander; Martti T Tammi; Margareta Eriksson; Annelie Bjerkner; Annika Tiveljung-Lindell; Björn Andersson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-23       Impact factor: 11.205

3.  Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation.

Authors:  Miyuki Morozumi; Keiko Hasegawa; Reiko Kobayashi; Nagako Inoue; Satoshi Iwata; Haruo Kuroki; Naohisa Kawamura; Eiichi Nakayama; Takeshi Tajima; Kouichi Shimizu; Kimiko Ubukata
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

Review 4.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

5.  Antibiotic susceptibility according to genotype of penicillin-binding protein and macrolide resistance genes, and serotype of Streptococcus pneumoniae isolates from community-acquired pneumonia in children.

Authors:  Naoko Chiba; Reiko Kobayashi; Keiko Hasegawa; Miyuki Morozumi; Eiichi Nakayama; Takeshi Tajima; Satoshi Iwata; Kimiko Ubukata
Journal:  J Antimicrob Chemother       Date:  2005-08-30       Impact factor: 5.790

6.  Comparison of real-time PCR assays with fluorescent-antibody assays for diagnosis of respiratory virus infections in children.

Authors:  Jane Kuypers; Nancy Wright; James Ferrenberg; Meei-Li Huang; Anne Cent; Lawrence Corey; Rhoda Morrow
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

7.  Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States.

Authors:  Keiko Hasegawa; Kentarou Yamamoto; Naoko Chiba; Reiko Kobayashi; Kensuke Nagai; Michael R Jacobs; Peter C Appelbaum; Keisuke Sunakawa; Kimiko Ubukata
Journal:  Microb Drug Resist       Date:  2003       Impact factor: 3.431

8.  Real-time PCR assays for detection of bocavirus in human specimens.

Authors:  Xiaoyan Lu; Malinee Chittaganpitch; Sonja J Olsen; Ian M Mackay; Theo P Sloots; Alicia M Fry; Dean D Erdman
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

9.  Quantification of enterococci and human adenoviruses in environmental samples by real-time PCR.

Authors:  Jian-Wen He; Sunny Jiang
Journal:  Appl Environ Microbiol       Date:  2005-05       Impact factor: 4.792

10.  Diagnosis of human metapneumovirus and rhinovirus in patients with respiratory tract infections by an internally controlled multiplex real-time RNA PCR.

Authors:  S A Scheltinga; K E Templeton; M F C Beersma; E C J Claas
Journal:  J Clin Virol       Date:  2005-08       Impact factor: 3.168

View more
  43 in total

1.  Evaluation of the novel respiratory virus surveillance program: Pediatric Early Warning Sentinel Surveillance (PEWSS).

Authors:  Patricia A Armour; Linh M Nguyen; Michelle L Lutman; John P Middaugh
Journal:  Public Health Rep       Date:  2013 Sep-Oct       Impact factor: 2.792

2.  The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Authors:  John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

3.  Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogens.

Authors:  Maja Kodani; Genyan Yang; Laura M Conklin; Tatiana C Travis; Cynthia G Whitney; Larry J Anderson; Stephanie J Schrag; Thomas H Taylor; Bernard W Beall; Robert F Breiman; Daniel R Feikin; M Kariuki Njenga; Leonard W Mayer; M Steven Oberste; Maria Lucia C Tondella; Jonas M Winchell; Stephen L Lindstrom; Dean D Erdman; Barry S Fields
Journal:  J Clin Microbiol       Date:  2011-04-06       Impact factor: 5.948

Review 4.  Lessons learned and unlearned in periodontal microbiology.

Authors:  Ricardo Teles; Flavia Teles; Jorge Frias-Lopez; Bruce Paster; Anne Haffajee
Journal:  Periodontol 2000       Date:  2013-06       Impact factor: 7.589

Review 5.  The role of multiplex PCR in respiratory tract infections in children.

Authors:  Jens Christian Krause; Marcus Panning; Hartmut Hengel; Philipp Henneke
Journal:  Dtsch Arztebl Int       Date:  2014-09-19       Impact factor: 5.594

6.  Time to reconsider routine high-dose amoxicillin for community-acquired pneumonia in all Canadian children.

Authors:  Nipunie Srimalie Rajapakse; Joseph Varkey Vayalumkal; Otto Gerben Vanderkooi; Leah Jeanne Ricketson; James Duncan Kellner
Journal:  Paediatr Child Health       Date:  2016-03       Impact factor: 2.253

7.  Difference of clinical features in childhood Mycoplasma pneumoniae pneumonia.

Authors:  You-Sook Youn; Kyung-Yil Lee; Ja-Young Hwang; Jung-Woo Rhim; Jin-Han Kang; Joon-Sung Lee; Ji-Chang Kim
Journal:  BMC Pediatr       Date:  2010-07-06       Impact factor: 2.125

8.  Bronchial casts and pandemic (H1N1) 2009 virus infection.

Authors:  Maki Hasegawa; Yasuji Inamo; Tatsuo Fuchigami; Koji Hashimoto; Miyuki Morozumi; Kimiko Ubukata; Haruo Watanabe; Takashi Takahashi
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

9.  Uncomplicated pneumonia in healthy Canadian children and youth: Practice points for management.

Authors:  Nicole Le Saux; Joan L Robinson
Journal:  Paediatr Child Health       Date:  2015 Nov-Dec       Impact factor: 2.253

10.  Epidemiology and associations with climatic conditions of Mycoplasma pneumoniae and Chlamydophila pneumoniae infections among Chinese children hospitalized with acute respiratory infections.

Authors:  Zhengrong Chen; Wei Ji; Yuqing Wang; Yongdong Yan; Hong Zhu; Xuejun Shao; Jun Xu
Journal:  Ital J Pediatr       Date:  2013-05-25       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.